MELVILLE, N.Y., July 21, 2015 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has promoted Peter McCarthy to the position of President, Henry Schein Global Animal Health Group. Mr. McCarthy also joins the Company's Executive Management Committee.
In his new position, Mr. McCarthy will oversee the Company's global animal health business, which spans 19 countries, including the United States, Australia, New Zealand, Canada, Malaysia and 14 countries in Europe. In 2014, Henry Schein's global animal health business had sales of approximately $2.9 billion.
Prior to assuming his new position, Mr. McCarthy was President, Henry Schein International, with responsibility for Henry Schein's animal health businesses outside of the United States and Canada. Mr. McCarthy began his career at Henry Schein in 2010 with responsibility for the Company's animal health business in Europe.
"Under Peter's strategic leadership we have seen steady growth in our European and international animal health operations," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. "Peter is the ideal leader to unify our vision for expanding our global animal health business and providing practitioners with the products, services and solutions needed to efficiently operate their practices and provide quality care."
Before joining Henry Schein, Mr. McCarthy held a variety of positions of increasing responsibility at Schering-Plough Animal Health (now Merck Animal Health) in both the United Kingdom and the United States, before serving as the company's Senior Director, Global Operations and General Manager, China. In these roles, Mr. McCarthy led global business development, as well as strategic planning. Prior to Schering-Plough Animal Health, Mr. McCarthy spent 14 years at Wyeth/American Cyanamid helping to grow its pharmaceutical business.
Mr. McCarthy holds a degree in Applied Biology from the University of Hertfordshire in the United Kingdom. He previously has served as a Member of the Board of the International Federation for Animal Health Europe, and the International Association Executive Animal Health Study Center, CEESA, based in Belgium. Mr. McCarthy is also a graduate and member of the Chartered Institute of Marketing (CIM), which is located in the U.K. He will be based at Henry Schein's worldwide headquarters in Melville, N.Y.
About Henry Schein, Inc.
Henry Schein, Inc. (NASDAQ:HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and the NASDAQ 100® indexes, Henry Schein employs more than 18,000 Team Schein Members and serves more than one million customers.
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and Henry Schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 30 countries. The Company's sales reached a record $10.4 billion in 2014, and have grown at a compound annual rate of approximately 16 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein and @HenrySchein on Twitter.
SOURCE Henry Schein, Inc.